Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts.

Maison, Patrick; Zureik, Mahmoud; Hivert, Virginie; Kjaer, Jesper; Hossein Khonsari, Roman; Trifirõ, Gianluca; Ratignier-Carbonneil, Christelle

Maison, Patrick; Zureik, Mahmoud; Hivert, Virginie; Kjaer, Jesper; Hossein Khonsari, Roman; Trifirõ, Gianluca; Ratignier-Carbonneil, Christelle.

Afiliación

Maison P; ANSM, Paris, France.
Zureik M; Faculté de Santé, Université Paris-Est Créteil, Créteil, France.
Hivert V; Epi-Phare, Saint Denis, France.
Kjaer J; EURORDIS, Paris, France.
Hossein Khonsari R; Data Analytics Centre, Danish Medicines Agency, Copenhagen, Denmark.
Trifirõ G; Health Data Hub, Paris, France.
Ratignier-Carbonneil C; Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Front Pharmacol ; 13: 969091, 2022.

Article en En | MEDLINE | ID: mdl-35959441

Palabras clave

big data; patient engagement; pharmacoepidemiology; pharmacovigilance; real-world data (RWD); real-world evidence (RWE); regulatory agencies; regulatory science

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Francia